Treatment outcome and risk factors for visual loss in Cytomegalovirus endotheliitis. - Wikidata - awgldk - TriplyDB

Treatment outcome and risk factors for visual loss in Cytomegalovirus endotheliitis.

Treatment outcome and risk factors for visual loss in Cytomegalovirus endotheliitis.

http://www.wikidata.org/entity/Q37926543

about

Interventions for the management of CMV-associated anterior segment inflammation Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications Aqueous cytokine changes associated with Posner-Schlossman syndrome with and without human cytomegalovirus.Clinical features and management of cytomegalovirus corneal endotheliitis: analysis of 106 cases from the Japan corneal endotheliitis study.Interventions for the management of CMV-associated anterior segment inflammation.The effect of topical application of 0.15% ganciclovir gel on cytomegalovirus corneal endotheliitis.Concomitant herpes simplex virus and cytomegalovirus endotheliitis in immunocompetent patient.Long-term results of oral valganciclovir for treatment of anterior segment inflammation secondary to cytomegalovirus infection.

P2860

Q24186844-ACFD6F32-AC7E-4155-8E4D-CE73281E8D61 Q27026675-BEEED578-D3E4-4BE9-A06E-FDE2F3F3E923 Q34427095-B663852F-702C-459A-840D-80BB088DCA86 Q34818853-584AD0CD-FFE6-457F-9889-2AE1993D28E9 Q38609877-69AEA005-AEA4-44EC-8F8B-D672850EDA07 Q40689089-8DC5F293-2C9E-454D-81DD-FD42301A2D8F Q41357421-4D20EF9F-3944-425B-A50F-14852B2B0501 Q42006963-BC7CEAC3-ED3A-43AC-8959-A37415190CCC

P2860

Treatment outcome and risk factors for visual loss in Cytomegalovirus endotheliitis.

http://www.wikidata.org/entity/Q37926543

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Treatment outcome and risk factors for visual loss in Cytomegalovirus endotheliitis.

@en

Treatment outcome and risk factors for visual loss in Cytomegalovirus endotheliitis.

@nl

type

label

Treatment outcome and risk factors for visual loss in Cytomegalovirus endotheliitis.

@en

Treatment outcome and risk factors for visual loss in Cytomegalovirus endotheliitis.

@nl

prefLabel

Treatment outcome and risk factors for visual loss in Cytomegalovirus endotheliitis.

@en

Treatment outcome and risk factors for visual loss in Cytomegalovirus endotheliitis.

@nl

P1433

Q37926543-D2D18343-4DD1-43B0-A0FE-803877D172B6

P1476

Q37926543-F7C61F7F-9E79-4301-8FAF-C05BA525B7C9

P2093

Q37926543-73F6FEEC-438A-44CD-BBA8-0E423BDA099C

Q37926543-9A04E720-6859-4861-ABA4-34C81FBECDA8

P2860

Q37926543-123268D2-79AB-4A79-8A31-D4174607E584

Q37926543-1CEB3303-8CEB-4F2A-97ED-72A8F163A859

Q37926543-21E46C54-8E0B-4F27-9701-A913E3034C4A

Q37926543-37C85E39-3C87-470D-B8D4-C1368BB1C8AA

Q37926543-42A786C0-DC69-420C-B046-BB0309D43D97

Q37926543-47F1B60A-FA3E-4DE1-A644-1BCD5991EC90

Q37926543-4ACD831C-4962-40E6-B386-FA8D77DB85AA

Q37926543-4EB5C7E3-E947-42D4-879B-98CDEA5A335D

Q37926543-6818BBFE-C4D1-4D87-9F81-A6DF5A1806D2

Q37926543-72642406-AA61-4A9A-81EB-1CB2C5D104EB

P2888

Q37926543-A3B79E8D-BCE9-4516-9884-A61141ACC7E7

P304

Q37926543-F6C65B64-B860-4109-A786-D78C76ED04BF

P31

Q37926543-BF86C929-3A26-4A84-ADB7-3AEEE9385B7C

P356

Q37926543-5BCE26ED-08D0-4C42-B33E-9D90F9842236

P433

Q37926543-F22CDDD8-6D29-4157-82CB-2063C327B158

P478

Q37926543-9714CAF4-4A9B-426C-A46C-473319F2A410

P577

Q37926543-B73AF745-7EBD-4652-BD57-72DE0E0E6278

P698

Q37926543-1EE99EF5-7B05-407C-9F5C-D4F8E3317508

P921

Q37926543-C3929964-B630-4F2B-8AA6-CE69D83728C9

P356

S00417-011-1813-7

P1433

Graefe's Archive for Clinical and Experimental Ophthalmology

P1476

Treatment outcome and risk factors for visual loss in Cytomegalovirus endotheliitis.

@en

P2093

Aliza Jap

http://www.w3.org/2001/XMLSchema#string

Soon-Phaik Chee

http://www.w3.org/2001/XMLSchema#string

P2860

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

Kinetics of aqueous flare, intraocular pressure and virus-DNA copies in a patient with cytomegalovirus iridocyclitis without retinitis.

Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis.

Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.

Cytomegalovirus as an etiologic factor in corneal endotheliitis.

Cytomegalovirus endotheliitis in Descemet's stripping endothelial keratoplasty.

Optic disc parameters and onset of glaucomatous field loss. II. Static screening criteria.

Prevalence and features of keratitis with quantitative polymerase chain reaction positive for cytomegalovirus.

Corneal endotheliitis with cytomegalovirus infection of corneal stroma.

Validation of a diagnostic multiplex polymerase chain reaction assay for infectious posterior uveitis.

P2888

s00417-011-1813-7

P304

383-389

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00417-011-1813-7

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

250

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21892696

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus